POST Online Media Lite Edition



 

Agios Pharmaceuticals appoints Jacqualyn Fouse to board

Staff Writer |
Cambridge, Mass., USA - December 6, 2017, Cambridge, Mass., USA - Agios Pharmaceuticals, a pharmaceutical company, announced the appointment of Jacqualyn Fouse to its board of directors.




Dr. Fouse previously served as president and chief operating officer of Celgene Corporation until April 2017, and as a member of Celgene's board of directors through June 2017.

Dr. Fouse joined Celgene in 2010 as chief financial officer and was named president of the company's global hematology & oncology franchise in 2014.

Before joining Celgene, she served as chief financial officer of Bunge Limited.

Prior to Bunge, Dr. Fouse served as senior vice president, chief financial officer, and head of corporate strategy at Alcon Laboratoriesy.

Prior to her tenure with Alcon, she held a variety of senior leadership roles with international companies, spending almost a decade of her career in Switzerland.

LATEST 5 MOVES FROM Massachusetts 


What to read next

Jacqualyn A. Fouse new CFO at The Perrigo Company
Celgene Corporation: Jacqualyn A. Fouse new SVP and CFO
Celgene Corporation COO Jacqualyn Fouse to retire